PowerPoint Presentation

MARKET INTELLIGENCE . CONSULTING

www.techsciresearch.com

2016 – 2026

AUSTRALIA RESPIRATORY CARE DEVICE MARKET

FORECAST & OPPORTUNITIES

1

Scope of Report

Product of Interest (POI): Respiratory Care Device

Review Period

2016 – 2019

Base Year

2020

Estimated Year

2021

Forecast Period

2022 – 2026

Year Range

Respiratory Care is the health care discipline that specializes in the promotion of optimum cardiopulmonary function and health. Respiratory Therapists employ scientific principles to identify, treat and prevent acute or chronic dysfunction of the cardiopulmonary system. Knowledge and understanding of the scientific principles underlying cardiopulmonary physiology and pathophysiology, as well as biomedical engineering and technology, enable respiratory therapists to provide patient care services effectively.

Market Segmentation

PRODUCT TYPE

Therapeutic Devices

Monitoring Devices

Diagnostic Devices

Consumables & Accessories

REGION

Australia Capital Territory & New South Wales

Victoria and Tasmania

Queensland

Northern Territory & Southern Australia

Western Australia

INDICATON

Chronic Obstructive Pulmonary Disease

Sleep Apnea

Asthma

Infectious Diseases

Others

END USER

Hospitals & Clinics

Ambulatory Care Centres

Others

‹#›

Table of Contents

S. No.ContentsPage No.1. Product Overview (Definition of product and major terminologies used in the report)2. Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys)3.Executive Summary4.Voice of Customer5.Impact of COVID-19 on Australia Respiratory Care Device Market6.Australia Respiratory Care Device Market Outlook, 2016-2026 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1.By Product Type (Therapeutic Devices, Monitoring Devices, Diagnostic Devices, Consumables & Accessories)6.2.2.By Indication (Chronic Obstructive Pulmonary Disease, Sleep Apnea, Asthma, Infectious Diseases, Others)6.2.3.By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)6.2.4.By Region6.2.5.By Company (2020)6.3.Product Market Map

‹#›

Table of Contents

S. No.ContentsPage No.7.Australia Respiratory Care Therapeutic Devices Market Outlook, 2016-2026 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1.By Type (Ventilators, Pap Devices, Nebulizers, Oxygen Concentrators, Humidifiers, Inhalers, Others) 7.2.2.By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)8.Australia Respiratory Care Monitoring Devices Market Outlook, 2016-20268.1.Market Size & Forecast 8.1.1.By Value 8.2.Market Share & Forecast 8.2.1.By Type (Pulse Oximeters, Gas Analyzers, Capnographs) 8.2.2By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)9.Australia Respiratory Care Diagnostic Devices Market Outlook, 2016-20269.1.Market Size & Forecast 9.1.1.By Value 9.2.Market Share & Forecast 9.2.1.By Type (Spirometers, Peak Flow Meters, Polysomnography (Psg) Devices)9.2.2.By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)

‹#›

Table of Contents

S. No.ContentsPage No.10.Australia Respiratory Care Consumables & Accessories Market Outlook, 2016-2026 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1.By Type (Masks, Breathing Circuits, Disposable Resuscitators, Others) 10.2.2.By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)11.Market Dynamics 11.1. Drivers Drivers 11.2. Challenges Challenges12.Market Trends & Developments13.Policy & Regulatory Landscape14.Australia Economic Profile15.Competitive Landscape 15.1.Competition Outlook15.2.Company Profiles 15.2.1.Company Details 15.2.1.Products & Services

‹#›

Table of Contents

S. No.ContentsPage No. 15.1.3.Financials (As Reported) 15.1.4.Key Market Focus & Geographical Presence15.1.5.Recent Developments15.1.6.Key Management Personnel16. Strategic14 Recommendations (Based on the findings of the report strategic recommendations on how to enter and expand market share)17. About Us & Disclaimer

‹#›

RESEARCH

METHODOLOGY

Research Methodology

Identifying Key Opinion Leaders

Questionnaire Design

In-depth Interviews

Data Collection

Developing List of Respondents

Formulating Questionnaire

Market Profiling

Data Validation

Data Analysis

In-depth secondary research was conducted to determine top players in Australia respiratory care market, overall market size and segmental market size.

In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide.

List of industry players and industry specialists was developed.

TechSci conducted interviews with industry experts and industry players for data collection and verification.

Data obtained as a result of primary and secondary research was validated through rigorous triangulation.

The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about Australia respiratory care market.

Data

Collection

Data Filter

& Analysis

Research &

Intelligence

Actionable

Insights

Business

Solution

Primary Research

Desk Research

Company Analysis

Recent Developments

Market Changing Aspects/Dynamics

Government Policies

Conclusion

Market Participants

Key Strengths

LinkedIn

TechSci Internal Database

Factiva

Hoovers

Paid Sources

Company Websites

Company Annual Reports

White Paper Study

Financial Reports

Investor Presentations

Regulatory Body

Associations, etc.

Secondary Research

Primary Research

‹#›

Research Methodology

Baseline Methodology

Our dedicated team of industry experts has monitored and analyzed various aspects of Australia respiratory care market. The team has analyzed the outlook of various segments of this market, while considering the major influencing factors such as growing demand for respiratory care. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in Australia respiratory care market.

Methodology Followed for Calculation of Market Size:

Market Size by Value: Market size, in terms of value, for the year 2020 was calculated based on information collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as respiratory care companies, channel partners, end-user industry experts, and other industry participants.

The team interviewed more than 15-20 respiratory care market companies, 100 – 120 end use industries, and 15 – 20 industry experts and other value chain stakeholders in Australia respiratory care market to obtain the overall market size for 2016-2020, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data for 2016-2020.

‹#›

9

Research Methodology

Respondents were asked about the current and future market growth rates, market shares by product type, by indication, by end user by region and by company. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.

Methodology Followed for Calculation of Market Shares:

Market shares by product type, by indication, by end user by region and by company were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of respiratory cares market. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.

Methodology Followed for Forecasting:

TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.

Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast Australia respiratory care market, TechSci Research used various forecast techniques such as:

Moving Average

Time Series Analysis

Regression Analysis

Econometric and Judgmental Analysis

‹#›

Research Methodology

TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long- term period to estimate and analyse market demand scenario. It should be noted that the figures compiled are only for the organized market including market share data.

Partial List of Companies Interviewed Key Secondary SourcesGE Healthcare Australia Pty Ltd.Medtronic Australasia Pty LtdResMed Inc (Australia)Koninklijke Philips N.V. (Australia)Invacare AustraliaDraeger Australia Pty. Ltd.Fisher & Paykel Healthcare Pty LimitedOmron Healthcare AustraliaMasimo Australia Pty. Ltd.Bird Healthcare (BHC)World BankTechSci Research Proprietary Database & Knowledge RepositoryCompany Annual Reports Industry MagazinesIndustry ReportsNews DailiesCredible Paid Databases

© TechSci Research

‹#›

Industry Brief

According to TechSci report, “Australia Respiratory Care Devices Market By Product Type (Therapeutic Devices, Monitoring Devices, Diagnostic Devices, Consumables & Accessories), By Indication (Chronic Obstructive Pulmonary Disease, Sleep Apnea, Asthma, Infectious Diseases, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast & Opportunities, 2026”, Australia respiratory care devices is anticipated to grow on account of the increasing number of respiratory disorders in the country and the surge in the demand for early diagnosis, and effective treatment in the forecast period, 2022-2026. The market is expected to grow on the attributes like rapid growth in the geriatric population, rising incidence of chronic diseases (including COPD and asthma), and the cost advantages of home care devices and services . High growth potential in emerging markets, healthcare decentralization, and the evolution of miniaturized devices  are some of the growth sectors that new players can exploit to settle their own market and flourish if the focus on the mentioned attributes. Moreover, owing to the rising healthcare costs, a large number of patients suffering from chronic respiratory diseases prefer to undergo treatments in home care settings. This trend is expected to increase the demand for products such as nebulizers, ventilators, and CPAP devices, as they are used by patients to treat, diagnose, and monitor a variety of respiratory diseases in home care settings, thereby supporting the growth of the Australia respiratory care devices market in the next five years, until 2026. Respiratory care devices refer to medical equipment which is used for the diagnosis, management, care, control, treatment and evaluation of patients with cardiopulmonary abnormalities. These are utilized in the cases of degenerative lung diseases including asthma, emphysema, chronic bronchitis, chronic and acute respiratory diseases. These devices include therapeutic devices like ventilators, pap devices, nebulizers, oxygen concentrators, humidifiers, inhalers, others; monitoring devices such as pulse oximeters, gas analyzers, capnographs. Diagnostic devices like spirometers, peak flow meters, polysomnography (PSG) devices, and other consumable & accessories like masks, breathing circuits, disposable resuscitators, others are the examples of respiratory care devices, the sales of which are rapidly increasing and thus driving the growth of the Australia respiratory care devices market in the next five years. The Australia respiratory care devices market is segmented by product type, indication, end user, competitive landscape, and regional distribution. Based on the indication, the market is further fragmented into chronic obstructive pulmonary disease, sleep apnea, asthma, infectious diseases, and others. Chronic obtrusive pulmonary disorder (COBD) is a very severe lung disorder, which is affecting not only the Australian population, but is prevalent across the whole world. The rising instances of the disease is catering to the growth of the sub-segment of the market and hereby recording maximum sales of the respiratory care devices required in the treatment, early diagnosis and post-surgery care. Increasing instances of smoking, vehicular smoke emissions and industrialization are also driving the growth of the market by causing the patient suffering from respiratory disorders.  Growing incidences of preterm birth, increase in urbanization and pollution and changing environment and lifestyle of people, along with presence of a strong pipeline of products awaiting approval is anticipated to affect the market growth in future five years, positively.

Some of the top players in the Australia respiratory care devices market are, GE Healthcare Australia Pty Ltd., Medtronic Australasia Pty Ltd, ResMed Inc (Australia), Koninklijke Philips N.V. (Australia), Invacare Australia, Draeger Australia Pty. Ltd., Fisher & Paykel Healthcare Pty Limited, Omron Healthcare Australia, 3M Australia,  Masimo Australia Pty. Ltd., among others. The companies are involving themselves into research and development to provide better quality products.

“New players may consider investing in the research and development of the technological advanced respiratory care devices. Healthcare industry in the country is developed and further upgradation is also continued , and thus, the boom in the market is confirmed. Research and development is appreciated  by governmental aids too. New players entering in the market with investments in the development of the technologically advanced products would ensure the growth of the market in the upcoming five years,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

‹#›

12

Sample Data - Snapshot

Australia Respiratory Care Device Market Size, By Value (USD Million), 2016-2026F

Australia Respiratory Care Therapeutic Devices Market Share, By Product Type, By Value, 2016–2026F

Australia Respiratory Care Therapeutic Devices Market Share, By End User, By Value, 2016–2026F

‹#›

13

By Value (USD Million)

201620202021E2026F56789101112131415

Ventilators

201620172018201920202021E2022F2023F2024F2025F2026F0.20.20.20.20.20.20.20.20.20.20.2Pap Devices

201620172018201920202021E2022F2023F2024F2025F2026F0.20.20.20.20.20.20.20.20.20.20.2Nebulizers

201620172018201920202021E2022F2023F2024F2025F2026F0.20.20.20.20.20.20.20.20.20.20.2Oxygen Concentrators

201620172018201920202021E2022F2023F2024F2025F2026F0.10.10.10.10.10.10.10.10.10.10.1Humidifiers

201620172018201920202021E2022F2023F2024F2025F2026F0.10.10.10.10.10.10.10.10.10.10.1Inhalers

201620172018201920202021E2022F2023F2024F2025F2026F0.10.10.10.10.10.10.10.10.10.10.1Others

201620172018201920202021E2022F2023F2024F2025F2026F0.10.10.10.10.10.10.10.10.10.10.1

Hospitals & Clinics

201620172018201920202021E2022F2023F2024F2025F2026F0.50.50.50.50.50.50.50.50.50.50.5Ambulatory Care Centers

201620172018201920202021E2022F2023F2024F2025F2026F0.250.250.250.250.250.250.250.250.250.250.25Others

201620172018201920202021E2022F2023F2024F2025F2026F0.250.250.250.250.250.250.250.250.250.250.25

Report Ordering

License Type PriceElectronic Access - Single User License$3450Electronic Access - Multi-User License$4450Custom Research License$8450

Report Price

To View Sample OR Purchase Report

Report Name: AUSTRALIA RESPIRATORY CARE DEVICE MARKET

FORECAST & OPPORTUNITIES

2016 – 2026

‹#›

14

About Us & Disclaimer

TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.

Related Reports

Global CAR-T Cell Therapy Market By Indication (Diffused Large B-cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma (MM), Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma (FL), Others), By Targeted Antigen(CD 19, CD22, BCMA (B-Cell Maturation Antigen), HER1, HER2, Meso, EGFRvlll, Others), By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel), JCAR017 (Lisocabtagene Maraleucel), bb2121), By End User (Hospitals, Cancer Treatment Centers, Others), By Region, Forecast & Opportunities, 2025

Global Oncology Drugs Market By Drug Type (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By Drug Therapy (Adjuvant, Neoadjuvant and Concurrent), By Route of Administration (Oral, Intravenous, Subcutaneous, Others), By Gender (Male, Female), By Cancer Type (Lung Cancer, Stomach Cancer, Others), By Distribution Channel (Hospital Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2025

The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.

TechSci Research – North America

708 Third Avenue, Manhattan,

New York, United States

Tel: +1- 646- 360- 1656

Email: sales@techsciresearch.com www.techsciresearch.com

Disclaimer

TechSci Research – Europe

54, Old brook, Bretton,

Peterborough,

United Kingdom

Email: sales@techsciresearch.com www.techsciresearch.com

TechSci Research – Asia-Pacific

B – 44, Sector – 57, Noida, National Capital Region, U.P. - India

Tel: +91-120-4523900

Email: sales@techsciresearch.com www.techsciresearch.com

15